Dental Care Clinics in Menomonie, WI Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Cedar Creek Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3101 Schneider Ave Se, Suite 1, Menomonie, WI 54751 Phone: 715-233-1400 |
Gentle Dental Care Sc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1813 Wilson St, Menomonie, WI 54751 Phone: 715-235-7566 Fax: 715-235-7578 |
Leipnitz Dental Clinic, Sc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 2521 Broadway St S, Menomonie, WI 54751 Phone: 715-235-7371 Fax: 715-235-7380 |
Gentle Dental Care Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1813 Wilson St., Menomonie, WI 54751 Phone: 715-235-7566 Fax: 715-235-7578 |
Cesa #11 Rural Health Dental Clinic Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 3375 Kothlow Ave., Suite 40, Menomonie, WI 54751 Phone: 715-235-1573 Fax: 715-235-2081 |
Red Cedar Dentistry Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 2409 Hils Ct, Menomonie, WI 54751 Phone: 715-309-2999 Fax: 715-309-2983 |
Menomonie Dental, Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 1603 Stout Rd, Menomonie, WI 54751 Phone: 715-235-6858 |
News Archive
Study shows that heart transplantation using donation after cardiac death with NRP is feasible in the U.S.
A new study, presented today at the AATS 101st Annual Meeting, found that heart transplantation using donation after cardiac death (DCD) with normothermic regional perfusion (NRP) is feasible in the United States.
BMY announces BMS-790052 plus PEG-Interferon alfa and RBV Phase II trial results against HCV
Bristol-Myers Squibb Company today announced results from a Phase II clinical trial in which treatment with the investigational direct-acting antiviral BMS-790052, an NS5A replication complex inhibitor, in combination with PEG-Interferon alfa and ribavirin, achieved sustained virologic response 12 weeks post-treatment in up to 92% of treatment-naïve patients chronically infected with hepatitis C genotype 1.
Johns Hopkins scientists identify protein fragment which may lead to a simple test for multiple sclerosis
Johns Hopkins scientists report the discovery of a protein found only in cerebrospinal fluid that they say might be useful in identifying a subgroup of patients with multiple sclerosis (MS) or identifying those at risk for the debilitating autoimmune disorder.
Ribavirin Biopartners 200mg film-coated tablets granted EU marketing approval
Biopartners GmbH has announced that it has received EU marketing authorization from the European Commission for Ribavirin Biopartners 200mg film-coated tablets. The product is intended for the treatment of chronic hepatitis C infection as part of a combination regimen with peginterferon alfa-2b or interferon alfa-2b.
› Verified 7 days ago